SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-101759
Filing Date
2017-03-29
Accepted
2017-03-29 16:27:00
Documents
3
Period of Report
2017-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d352087d6k.htm 6-K 10164
2 EX-99.1 d352087dex991.htm EX-99.1 293318
3 GRAPHIC g352087g0329124152268.jpg GRAPHIC 2862
  Complete submission text file 0001193125-17-101759.txt   308697
Mailing Address 85B PARK DRIVE MILTON PARK ABINGDON X0 OX14 4RY
Business Address 85B PARK DRIVE MILTON PARK ABINGDON X0 OX14 4RY 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 17722552
SIC: 2834 Pharmaceutical Preparations